Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Consulting agrmnt
Appointed director
|
|
Guardion Health Sciences, Inc. (GHSI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2022 |
8-K/A
| Investor presentation |
| 08/10/2021 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits|
Docs:
|
"Consent of KPMG LLP, the independent auditors of Activ Nutritional, LLC",
"The audited financial statements and related notes thereto of Activ Nutritional, LLC as of and for the years ended December 31, 2020 and 2019, including the related audit report of the independent auditors, KPMG LLP, and the unaudited interim condensed financial statements and related notes thereto for the three months ended March 31, 2021 and 2020",
"The unaudited pro forma condensed combined financial information of Guardion Health Sciences, Inc., giving effect to the acquisition of Activ Nutritional, LLC, which includes the unaudited pro forma condensed combined balance sheet and related notes as of March 31, 2021 and the unaudited pro forma condensed combined statements of operations and related notes thereto for the three months ended March 31, 2021 and the year ended December 31, 2020" |
|
| 08/10/2021 |
8-K/A
| Quarterly results |
| 11/21/2017 |
8-K/A
| Other Events, Financial Statements and Exhibits |
| 08/03/2017 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Guardion Health Sciences announces completion of Series B funding round, raising over $3 million San Diego, California – August 3rd, 2017 – Guardion Health Sciences, Inc. , a leader in the field of ocular health technologies and products, completed their Series B funding round closing on July 31st , 2017, raising an aggregated total of $3.105 million. The Company intends to use the proceeds to accelerate expansion of their operations, implement their sales and marketing strategy, and complete development of additional products in their pipeline. Guardion Health Sciences, Inc. is a specialty health sciences company that develops, formulates and distributes condition-specific medical foods with an initial medical food product that addresses a depleted macular protective pigment, a known risk..." |
|
| 01/18/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|